After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...